Skip to content

Clinical trials

Terminated Phase 1/2 Lymphoma, T-Cell, Cutaneous trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Phase 1/2 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20061
20081
20101
20133
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Northwestern University2
Columbia University1
Emory University1
Jennifer Amengual1
Stanford University1
University of Michigan1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous10
Mycosis Fungoides6
Lymphoma, Follicular5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Non-Hodgkin5
Sezary Syndrome5
Hodgkin Disease4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Large-Cell, Anaplastic4

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.